Physician profile
David Kee Tom
NPI 1043491988
$3,763.00
in general payments reported to CMS, 2019-2025
20 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,415 · 2020: $224 · 2021: $189 · 2022: $94.62 · 2023: $38.71 · 2024: $480 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,430.71 | 2019 | |
| Boston Scientific Corporation | $587.31 | 2019-2025 | Intracept, Superion Indirect Decompression System |
| Abbott Laboratories | $563.46 | 2019-2025 | Octrode, Proclaim |
| Nevro Corp. | $332.70 | 2019-2022 | |
| Spinal Simplicity, LLC | $147.47 | 2024 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $145.76 | 2019-2020 | |
| Biotronik Nro, INC. | $125.00 | 2024 | Prospera |
| Relievant Medsystems, INC. | $112.67 | 2021 | |
| Spr Therapeutics, INC | $64.63 | 2019 | |
| Bioventus LLC | $38.41 | 2019 | |
| Abbvie INC. | $31.30 | 2022-2023 | Ubrelvy |
| Depuy Synthes Sales INC. | $28.16 | 2019 | |
| Vertos Medical, INC. | $26.90 | 2019 | |
| Zyla Life Sciences, INC. | $24.58 | 2019 | |
| Stryker Corporation | $24.23 | 2025 | Mild Device Kit, Multigen 2 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.51 | 2019 | |
| Stimwave Technologies Incorporated | $13.95 | 2020 | |
| Painteq LLC | $13.67 | 2021 | |
| Assertio Therapeutics, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.